CINQAIR FDA approval date
The FDA approved CINQAIR on 23 Mar 2016.
- FDA approval date
- 23 Mar 2016
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as RESLIZUMAB
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2016-03-23Day | CINQAIR | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA761033", "applicant_as_listed_by_fda": "TEVA RESPIRATORY LLC", "brand_names": ["CINQAIR"], "active_ingredients": ["RESLIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160323", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |